Corbus Pharmaceuticals Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 812.00 shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 41.67K shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 41.67K shares, a 69.51% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 136.66K shares, a 211.76% increase from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 43.84K shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 27.95K shares, a 93.46% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 812.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 42.49K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | 41.67K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 41.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 41.67K shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 2.59K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-06 | 112.43K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 136.66K shares 10-K · filed 2025-03-11 |
| 2024-09-30 | 2.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 136.66K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 109.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | |
| 2024-03-31 | 24.23K shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 43.84K shares 10-K · filed 2024-03-12 |
| 2023-03-31 | 43.84K shares 10-Q · filed 2023-05-09 | |
| 2021-12-31 | -810.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 27.95K shares 10-K · filed 2023-03-07 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 1.02M shares derived: sum of 4 quarters · filed 2022-03-08 |
| 2021-06-30 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.06M shares derived: sum of 4 quarters · filed 2022-03-08 |
| 2021-03-31 | 788.60K shares 10-Q · filed 2021-05-13 | 1.07M shares derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-12-31 | 178.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 427.61K shares 10-K · filed 2022-03-08 |
| 2020-09-30 | 47.08K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | 249.58K shares derived: sum of 4 quarters · filed 2021-03-15 |
| 2020-06-30 | 51.60K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | 231.29K shares derived: sum of 4 quarters · filed 2021-03-15 |
| 2020-03-31 | 150.89K shares 10-Q · filed 2020-05-11 | 196.15K shares derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 107.03K shares 10-K · filed 2021-03-15 |
| 2019-09-30 | 28.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 117.03K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-06-30 | 16.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 128.23K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | 61.77K shares 10-Q · filed 2019-05-09 | 164.38K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 139.07K shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 40.00K shares 10-Q · filed 2018-11-08 | 161.99K shares derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | 52.60K shares 10-Q · filed 2018-08-08 | 124.49K shares derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | 36.47K shares 10-Q · filed 2018-05-10 | 148.65K shares derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | 32.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 272.73K shares 10-K · filed 2019-03-12 |
| 2017-09-30 | 2.50K shares 10-Q · filed 2018-11-08 | 307.32K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | 76.77K shares 10-Q · filed 2018-08-08 | 384.20K shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | 160.55K shares 10-Q · filed 2018-05-10 | |
| 2016-12-31 | 67.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 326.89K shares 10-K · filed 2018-03-12 |
| 2016-09-30 | 79.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2015-12-31 | 11.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 11.67M shares 10-K · filed 2018-03-12 |
| 2015-09-30 | 18.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | |
| 2015-06-30 | 30.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | |
| 2015-03-31 | 2.84K shares 10-Q · filed 2015-05-13 | |
| 2014-12-31 | 87.69K shares 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |